Toxicity of Pyroglutaminated Amyloid β‐Peptides 3(pE)‐40 and ‐42 Is Similar to That of Aβ1‐40 and ‐42
- 1 October 1999
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 73 (4) , 1584-1589
- https://doi.org/10.1046/j.1471-4159.1999.0731584.x
Abstract
: An N‐terminal truncated isoform of the amyloid β‐peptide (Aβ) that begins with a pyroglutamate (pE) residue at position 3 [Aβ3(pE)‐42] is the predominant isoform found in senile plaques. Based upon previous in vitro studies regarding Aβ N‐terminal truncated isoforms, it has been hypothesized that Aβ3(pE)‐x isoforms may aggregate more rapidly and become more toxic than corresponding Aβ1‐x peptides. However, the toxicity and aggregation properties of Aβ3(pE)‐42 and Aβ3(pE)‐40 have not previously been examined. After initial solubilization and 1‐week preaggregation of each peptide at 37°C and pH 7.4, the toxicity of 5‐50 μM Aβ3(pE)‐42 was similar to that of Aβ1‐42. Moreover, the toxicity of Aβ3(pE)‐40 paralleled that induced by Aβ1‐40 in both 1 day in vitro (DIV) cortical and 7 DIV hippocampal cells. Circular dichroism spectra did not reveal major differences in secondary structure between aged Aβ1‐42, Aβ3(pE)‐42, Aβ3(pE)‐40, and Aβ1‐40 or freshly solubilized forms of these peptides. Overall, the data indicate that the loss of the two N‐terminal amino acids and the cyclization of glutamate at position 3 do not alter the extracellular toxicity of Aβ.Keywords
This publication has 20 references indexed in Scilit:
- Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-AmyloidNeurobiology of Aging, 1998
- Reduction of Plasma Glutamyl Aminopeptidase Activity in Sporadic Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1997
- Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brainNeuroscience Letters, 1996
- Cerebral vessels in ageing and Alzheimer's diseasePharmacology & Therapeutics, 1996
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995
- Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in VitroJournal of Biological Chemistry, 1995
- Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neuronsExperimental Neurology, 1995
- Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaquesNeuron, 1995
- Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and NeurotoxicityJournal of Neurochemistry, 1995
- Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combinationJournal of Neuroscience Research, 1993